Topical Antiperspirant for Hand-Foot Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-05-31

Study Completion Date

2007-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are to evaluate the effectiveness of an antiperspirant in preventing or attenuating the severity of palmer-plantar erythrodysesthesia associated with the Food and Drug Administration (FDA)-approved doses of capecitabine. The hypothesis is that cytotoxic compounds in sweat will be prevented from being deposited in the skin and causing chronic toxicity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Physical Therapy Intervention on Foot and Ankle Function

NCT04930406

Neoplasms Physical Therapy Modalities Survivorship

RECRUITING

Impact of an Orthotic Intervention in Children With Peripheral Neuropathy

NCT03655587

Gait, Drop Foot Chemotherapy-induced Peripheral Neuropathy Acute Lymphocytic Leukemia, Pediatric +2 more

COMPLETED NA

Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes

NCT02316483

Charcot Arthropathy Type 2 Diabetes

COMPLETED

Perforating Fat Injections for Plantar Fasciosis

NCT02855983

Plantar Fascia

COMPLETED NA

DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

NCT02973269

Plantar Fasciitis

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palmar-plantar Erythrodysesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

antiperspirant topically to one foot once daily

Group Type EXPERIMENTAL

antiperspirant

Intervention Type DRUG

antiperspirant topically once daily to one foot

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

antiperspirant

antiperspirant topically once daily to one foot

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has not previously received a regimen that includes 5-fluorouracil
* \> 18 years old
* No known allergy or intolerance to Ban Unscented Roll-On Antiperspirant